Identifying cisplatin-induced kidney damage in paediatric oncology patients

Cisplatin is one chemotherapeutic agent used to treat childhood cancer in numerous treatment protocols, including as a single agent. It is likely to remain in clinical use over the long term. However, cisplatin-related toxicities, including neurotoxicity and nephrotoxicity, are common, affecting tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Barton, Chris D., Pizer, Barry, Jones, Caroline, Oni, Louise, Pirmohamed, Munir, Hawcutt, Daniel B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061670/
https://www.ncbi.nlm.nih.gov/pubmed/28821959
http://dx.doi.org/10.1007/s00467-017-3765-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061670/
https://www.ncbi.nlm.nih.gov/pubmed/28821959
http://dx.doi.org/10.1007/s00467-017-3765-6

Ejemplares similares